FdaApplication
BLA 125011
Identifiers
- fda_app_no: BLA125011
Properties
| Property | Value |
|---|---|
| applicant_name | GlaxoSmithKline LLC |
| application_type | BLA |
| approval_date | 2003-06-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BEXXAR | — | 35MG | Injection |
| BEXXAR | — | 225MG | Injection |
2 products